Guanfacine shows promise in treating ADHD by strengthening synaptic connections in prefrontal circuitry, contrasting with traditional stimulants that act quickly by boosting dopamine. Unlike other medications, guanfacine works more gradually, modulating glutamate activity through alpha 2 receptors. Patient experiences highlight the immediate effects of other drugs, challenging the notion that non-stimulants take longer to show benefits.
